Published in Pharmacol Rev on December 01, 2004
Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume | NCT04885153
The metabolic syndrome: A high-risk state for cancer? Am J Pathol (2006) 2.46
Age-related changes in Drosophila midgut are associated with PVF2, a PDGF/VEGF-like growth factor. Aging Cell (2008) 2.09
Crossing the endothelial barrier during metastasis. Nat Rev Cancer (2013) 2.00
The VEGF family in cancer and antibody-based strategies for their inhibition. MAbs (2011) 1.41
Prokaryotic Soluble Overexpression and Purification of Human VEGF165 by Fusion to a Maltose Binding Protein Tag. PLoS One (2016) 1.39
Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin Med (2007) 1.36
Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutr Cancer (2009) 1.31
A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network. Proc Natl Acad Sci U S A (2006) 1.29
Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha. J Biol Chem (2006) 1.24
Metabolic syndrome and cancer. Metab Syndr Relat Disord (2009) 1.24
Oxidative stress in angiogenesis and vascular disease. Blood (2013) 1.19
An evolving new paradigm: endothelial cells--conditional innate immune cells. J Hematol Oncol (2013) 1.17
Lasting controversy on ranibizumab and bevacizumab. Theranostics (2011) 1.15
Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature. Matrix Biol (2015) 1.15
Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems. J Artif Organs (2014) 1.14
Vulnerability of the developing brain to hypoxic-ischemic damage: contribution of the cerebral vasculature to injury and repair? Front Physiol (2012) 1.12
Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer. Breast Cancer Res Treat (2012) 1.11
Pathogenesis of preeclampsia: the genetic component. J Pregnancy (2011) 1.10
Angiogenesis and its therapeutic opportunities. Mediators Inflamm (2013) 1.09
Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury. Respir Res (2009) 1.09
Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1. Elife (2013) 1.06
Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging. Circ Res (2014) 1.06
The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinoma. PLoS One (2012) 1.04
The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion. Interact Cardiovasc Thorac Surg (2012) 1.03
Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions. Stem Cell Res (2013) 1.02
Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling. BMC Cancer (2013) 1.00
Long-term alterations of cytokines and growth factors expression in irradiated tissues and relation with histological severity scoring. PLoS One (2011) 1.00
Combination treatment with HER-2 and VEGF peptide mimics induces potent anti-tumor and anti-angiogenic responses in vitro and in vivo. J Biol Chem (2011) 0.99
Methyl jasmonate abolishes the migration, invasion and angiogenesis of gastric cancer cells through down-regulation of matrix metalloproteinase 14. BMC Cancer (2013) 0.98
Reduced BDNF attenuates inflammation and angiogenesis to improve survival and cardiac function following myocardial infarction in mice. Am J Physiol Heart Circ Physiol (2013) 0.97
In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments : In vitro augmentation of mesenchymal stem cells viability. Cell Stress Chaperones (2014) 0.97
Generation of erythroid cells from fibroblasts and cancer cells in vitro and in vivo. Cancer Lett (2013) 0.97
Accelerated wound healing mediated by activation of Toll-like receptor 9. Wound Repair Regen (2010) 0.97
Autophagy triggered by magnolol derivative negatively regulates angiogenesis. Cell Death Dis (2013) 0.96
Novel polymeric scaffolds using protein microbubbles as porogen and growth factor carriers. Tissue Eng Part C Methods (2010) 0.96
Growth factors in the treatment of early osteoarthritis. Clin Cases Miner Bone Metab (2013) 0.95
Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo. Angiogenesis (2011) 0.95
Chronic morphine treatment inhibits LPS-induced angiogenesis: implications in wound healing. Cell Immunol (2010) 0.95
Beyond antiangiogenesis: vascular modulation as an anticancer therapy-a review. Transl Oncol (2012) 0.95
Synthesis and mechanistic studies of a novel homoisoflavanone inhibitor of endothelial cell growth. PLoS One (2014) 0.94
VEGF-initiated angiogenesis and the uPA/uPAR system. Cell Adh Migr (2012) 0.94
An important role of blood and lymphatic vessels in inflammation and allergy. J Allergy (Cairo) (2013) 0.94
Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. J Clin Invest (2016) 0.94
Myeloid derived hypoxia inducible factor 1-alpha is required for protection against pulmonary Aspergillus fumigatus infection. PLoS Pathog (2014) 0.93
Meta-analysis of archived DNA microarrays identifies genes regulated by hypoxia and involved in a metastatic phenotype in cancer cells. BMC Cancer (2010) 0.93
Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival. J Cell Mol Med (2013) 0.92
Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses. Exp Lung Res (2011) 0.92
Transcriptome-wide landscape of pre-mRNA alternative splicing associated with metastatic colonization. Mol Cancer Res (2014) 0.91
Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation. PLoS One (2014) 0.91
Brain pericytes: emerging concepts and functional roles in brain homeostasis. Cell Mol Neurobiol (2011) 0.91
Endothelial differentiation of SHED requires MEK1/ERK signaling. J Dent Res (2012) 0.91
Chronic hypoxia and VEGF differentially modulate abundance and organization of myosin heavy chain isoforms in fetal and adult ovine arteries. Am J Physiol Cell Physiol (2012) 0.91
Soluble THSD7A is an N-glycoprotein that promotes endothelial cell migration and tube formation in angiogenesis. PLoS One (2011) 0.90
Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction. Funct Integr Genomics (2010) 0.90
Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling. Oncogene (2014) 0.90
In vivo optical imaging of tumor and microvascular response to ionizing radiation. PLoS One (2012) 0.90
Metabolic syndrome and renal cell carcinoma. World J Surg Oncol (2014) 0.90
MicroRNA control of vascular endothelial growth factor signaling output during vascular development. Arterioscler Thromb Vasc Biol (2013) 0.90
Multiple roles of COUP-TFII in cancer initiation and progression. J Mol Endocrinol (2012) 0.89
IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer. Oncotarget (2016) 0.89
Systems pharmacology approaches for optimization of antiangiogenic therapies: challenges and opportunities. Front Pharmacol (2015) 0.89
Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis. Oncotarget (2015) 0.88
Injury-Mediated Vascular Regeneration Requires Endothelial ER71/ETV2. Arterioscler Thromb Vasc Biol (2015) 0.88
Differentiation of umbilical cord lining membrane-derived mesenchymal stem cells into endothelial-like cells. Iran Biomed J (2014) 0.88
Leukocyte driven-decidual angiogenesis in early pregnancy. Cell Mol Immunol (2014) 0.88
Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung. PLoS One (2013) 0.88
BMP signaling through BMPRIA in astrocytes is essential for proper cerebral angiogenesis and formation of the blood-brain-barrier. Mol Cell Neurosci (2008) 0.88
Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy. Future Oncol (2012) 0.88
Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets. Pharmacol Ther (2012) 0.88
Cytokine-release kinetics of platelet-rich plasma according to various activation protocols. Bone Joint Res (2016) 0.88
Cell and molecular mechanisms of insulin-induced angiogenesis. J Cell Mol Med (2010) 0.88
PGC-1α induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle. Circ Res (2014) 0.87
Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review. Surv Ophthalmol (2015) 0.87
Regulation of angiogenesis by aminoacyl-tRNA synthetases. Int J Mol Sci (2014) 0.86
Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model. Oncotarget (2015) 0.86
The small molecule Wnt signaling modulator ICG-001 improves contractile function in chronically infarcted rat myocardium. PLoS One (2013) 0.86
Efficacious and clinically relevant conditioned medium of human adipose-derived stem cells for therapeutic angiogenesis. Mol Ther (2013) 0.86
Neuropilin regulation of angiogenesis, arteriogenesis, and vascular permeability. Microcirculation (2014) 0.85
Three-dimensional spheroid cell culture of umbilical cord tissue-derived mesenchymal stromal cells leads to enhanced paracrine induction of wound healing. Stem Cell Res Ther (2015) 0.85
Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor. Int J Ophthalmol (2013) 0.85
Relationship of plasma and synovial fluid vascular endothelial growth factor with radiographic severity in primary knee osteoarthritis. Int Orthop (2013) 0.85
Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis. Mol Cancer (2013) 0.85
The neurotensin-HIF-1α-VEGFα axis orchestrates hypoxia, colonic inflammation, and intestinal angiogenesis. Am J Pathol (2014) 0.85
Recent insights into the actions of IGFBP-6. J Cell Commun Signal (2015) 0.85
Associations between prenatal traffic-related air pollution exposure and birth weight: Modification by sex and maternal pre-pregnancy body mass index. Environ Res (2015) 0.84
Contribution of increased VEGF receptors to hypoxic changes in fetal ovine carotid artery contractile proteins. Am J Physiol Cell Physiol (2013) 0.84
Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis. J Biol Chem (2015) 0.84
Mitogen-activated protein 3 kinase 6 mediates angiogenic and tumorigenic effects via vascular endothelial growth factor expression. Am J Pathol (2009) 0.84
Contributions of VEGF to age-dependent transmural gradients in contractile protein expression in ovine carotid arteries. Am J Physiol Cell Physiol (2011) 0.84
Identification of key contributory factors responsible for vascular dysfunction in idiopathic recurrent spontaneous miscarriage. PLoS One (2013) 0.84
Peripheral Blood-Derived Mesenchymal Stromal Cells Promote Angiogenesis via Paracrine Stimulation of Vascular Endothelial Growth Factor Secretion in the Equine Model. Stem Cells Transl Med (2014) 0.83
Granulocyte colony-stimulating factor attenuates delayed tPA-induced hemorrhagic transformation in ischemic stroke rats by enhancing angiogenesis and vasculogenesis. J Cereb Blood Flow Metab (2014) 0.83
Influence of subretinal fluid in advanced stage retinopathy of prematurity on proangiogenic response and cell proliferation. Mol Vis (2014) 0.83
Angiogenic therapy for cardiac repair based on protein delivery systems. Heart Fail Rev (2012) 0.83
Lectin-like oxidized LDL receptor-1 is an enhancer of tumor angiogenesis in human prostate cancer cells. PLoS One (2014) 0.83
Interaction between smoking and HLA-DRB1*04 gene is associated with a high cardiovascular risk in Brazilian Amazon patients with rheumatoid arthritis. PLoS One (2012) 0.83
Association of TNF-α and Fas gene promoter polymorphism with the risk of Kashin-Beck disease in Northwest Chinese population. Clin Rheumatol (2012) 0.83
The acceleration of wound healing in primates by the local administration of immunostimulatory CpG oligonucleotides. Biomaterials (2011) 0.83
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol (2013) 4.28
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials. Lancet Oncol (2012) 2.92
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol (2012) 2.16
International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol (2014) 2.13
The influence of clinical assessment (including age) and geriatric assessment on treatment decisions in older patients with cancer. J Geriatr Oncol (2013) 2.07
A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol (2012) 1.79
Taxanes and anthracyclines in early breast cancer: which first? Lancet Oncol (2010) 1.53
International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature. J Clin Oncol (2007) 1.50
International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer (2007) 1.44
Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers. Breast Cancer Res (2012) 1.39
11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat (2012) 1.26
Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging. Breast Cancer Res Treat (2006) 1.26
The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites. Cell Rep (2013) 1.26
Update on triple-negative breast cancer: prognosis and management strategies. Int J Womens Health (2012) 1.26
Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer. J Am Soc Echocardiogr (2008) 1.24
Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer. J Clin Oncol (2013) 1.20
Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist? J Clin Oncol (2008) 1.17
Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun (2006) 1.15
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One (2012) 1.13
Additional value of PET-CT in staging of clinical stage IIB and III breast cancer. Breast J (2010) 1.13
Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency. Carcinogenesis (2012) 1.12
Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management. Breast Cancer Res (2015) 1.12
A multifaceted study of Pseudomonas aeruginosa shutdown by virulent podovirus LUZ19. MBio (2013) 1.11
Performance of two geriatric screening tools in older patients with cancer. J Clin Oncol (2013) 1.09
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer. Breast Cancer Res (2013) 1.08
Triple-negative breast cancer. Curr Opin Oncol (2008) 1.07
Isolation and purification of a new kalimantacin/batumin-related polyketide antibiotic and elucidation of its biosynthesis gene cluster. Chem Biol (2010) 1.07
Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice. Breast (2012) 1.05
Peptidomics: the integrated approach of MS, hyphenated techniques and bioinformatics for neuropeptide analysis. J Sep Sci (2008) 1.03
Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma. Expert Opin Pharmacother (2008) 1.02
Why should results from metastatic trials no longer matter for early-stage disease? J Clin Oncol (2013) 0.99
Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis. J Clin Oncol (2010) 0.98
Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related. Breast Cancer Res Treat (2005) 0.97
Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive. Breast Cancer Res Treat (2008) 0.97
OdK2, a Kv1.3 channel-selective toxin from the venom of the Iranian scorpion Odonthobuthus doriae. Toxicon (2008) 0.96
Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients. Int J Radiat Oncol Biol Phys (2010) 0.96
The kalimantacin/batumin biosynthesis operon encodes a self-resistance isoform of the FabI bacterial target. Chem Biol (2010) 0.94
Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors. Breast Cancer Res Treat (2008) 0.94
Aromatase inhibitors in the breast cancer clinic: focus on exemestane. Endocr Relat Cancer (2014) 0.93
Thymosin beta 4 mRNA and peptide expression in phagocytic cells of different mouse tissues. Peptides (2009) 0.92
Detection and monitoring of cardiotoxicity-what does modern cardiology offer? Support Care Cancer (2008) 0.91
Pharmacology of anticancer drugs in the elderly population. Clin Pharmacokinet (2003) 0.91
ProteinChip technology is a useful method in the pathogenesis and diagnosis of endometriosis: a preliminary study. Fertil Steril (2006) 0.90
Proteolytic processing of ErbB4 in breast cancer. PLoS One (2012) 0.90
Analysis of the formalin-fixed paraffin-embedded tissue proteome: pitfalls, challenges, and future prospectives. Amino Acids (2013) 0.90
Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCR. Clin Cancer Res (2004) 0.89
Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy. Int J Radiat Oncol Biol Phys (2012) 0.89
Interindividual variation in the proteome of human peripheral blood mononuclear cells. PLoS One (2013) 0.89
Spectral clustering in peptidomics studies helps to unravel modification profile of biologically active peptides and enhances peptide identification rate. Proteomics (2009) 0.87
Triple negative breast cancer: clinical characteristics in the different histological subtypes. Breast (2013) 0.87
Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions. Genet Epidemiol (2013) 0.86
Impact of tumor chronology and tumor biology on lymph node metastasis in breast cancer. Springerplus (2013) 0.86
Safety and efficacy of weekly docetaxel in frail and/or elderly patients with metastatic breast cancer: a phase II study. Anticancer Drugs (2004) 0.86
Systematic identification of hypothetical bacteriophage proteins targeting key protein complexes of Pseudomonas aeruginosa. J Proteome Res (2014) 0.86
High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008). Support Care Cancer (2010) 0.86
Comparative peptidomics of Caenorhabditis elegans versus C. briggsae by LC-MALDI-TOF MS. Peptides (2008) 0.85
Mass spectrometric profiling of (neuro)-peptides in the worker honeybee, Apis mellifera. Neuropharmacology (2009) 0.85
Bioinformatic approaches to the identification of novel neuropeptide precursors. Methods Mol Biol (2010) 0.84
Study protocol of KLIMOP: a cohort study on the wellbeing of older cancer patients in Belgium and the Netherlands. BMC Public Health (2011) 0.83
Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model. Ann Thorac Surg (2002) 0.83
CA 19-9 and survival in advanced and unresectable pancreatic adenocarcinoma and cholangiocarcinoma. J Gastrointest Cancer (2007) 0.83
Docetaxel and gemcitabine combination therapy in advanced transitional cell carcinoma of the urothelium: results of a phase II and pharmacologic study. Anticancer Drugs (2007) 0.82
Fall predictors in older cancer patients: a multicenter prospective study. BMC Geriatr (2014) 0.82
Proteomic analysis of formalin-fixed paraffin-embedded colorectal cancer tissue using tandem mass tag protein labeling. Mol Biosyst (2013) 0.81
Immediate versus delayed self-reporting of symptoms and side effects during chemotherapy: does timing matter? Eur J Oncol Nurs (2010) 0.81
Lymph node ratio better predicts disease-free survival in node-positive breast cancer than the number of positive lymph nodes. J Clin Oncol (2009) 0.81
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy. Breast Cancer Res (2015) 0.79
A hybrid, de novo based, genome-wide database search approach applied to the sea urchin neuropeptidome. J Proteome Res (2010) 0.79
In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvement. J Clin Oncol (2008) 0.79
Adjuvant endocrine therapy for perimenopausal women with early breast cancer. Breast (2008) 0.79
Weekly paclitaxel versus weekly docetaxel in elderly or frail patients with metastatic breast carcinoma: a randomized phase-II study of the Belgian Society of Medical Oncology. Crit Rev Oncol Hematol (2009) 0.78
Comparison of extraction methods for peptidomics analysis of mouse brain tissue. J Neurosci Methods (2011) 0.78
Evaluation of the antibacterial and antibiofilm activities of novel CRAMP-vancomycin conjugates with diverse linkers. Org Biomol Chem (2015) 0.78
Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor. Menopause (2011) 0.78
Quantification of the anticancer agent STI-571 in erythrocytes and plasma by measurement of sediment technology and liquid chromatography-tandem mass spectrometry. J Chromatogr A (2003) 0.78
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients. Breast Cancer Res Treat (2015) 0.77
Peptidomic analysis of human reflex tear fluid. Peptides (2012) 0.77
Prospective assessment of the endometrium in postmenopausal breast cancer patients treated with fulvestrant. Breast Cancer Res Treat (2008) 0.76
Identification and relative quantification of neuropeptides from the endocrine tissues. Methods Mol Biol (2010) 0.76
Proteomics in cancer research: methods and application of array-based protein profiling technologies. Anal Chim Acta (2005) 0.76
APRP, the second peptide encoded by the adipokinetic hormone gene(s), is highly conserved in evolution: a role in control of ecdysteroidogenesis? Ann N Y Acad Sci (2009) 0.76
Reply to L.K. Mell et al. J Clin Oncol (2014) 0.75
Fertility preservation in (breast) cancer patients: is it safe? J Clin Oncol (2006) 0.75
Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection? Springerplus (2013) 0.75
Reproduction rates after cytotoxic therapy. J Clin Oncol (2009) 0.75
The benefits and limitations of reaction cell and sector field inductively coupled plasma mass spectrometry in the detection and quantification of phosphopeptides. Rapid Commun Mass Spectrom (2015) 0.75
The Leuven questionnaire on patient knowledge of chemotherapy (L-PaKC): instrument development and psychometric evaluation. Eur J Oncol Nurs (2012) 0.75
Anterograde versus retrograde isolated lung perfusion with melphalan in the WAG-Rij rat. Eur J Cardiothorac Surg (2005) 0.75
The relevance of therapeutic drug monitoring in plasma and erythrocytes in anti-cancer drug treatment. Clin Chem Lab Med (2004) 0.75
Phase I/II pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer. Clin Breast Cancer (2007) 0.75
Unexpected interactions between nicotinamide and CPT-11 in a rhabdomyosarcoma tumor model. Anticancer Res (2003) 0.75
Intra-hepatic Mitomycin C bolus infusion in the treatment of extensive liver metastases of breast cancer. Breast Cancer Res Treat (2007) 0.75